3 healthcare shares I would buy and hold forever

Thanks to ageing populations and increased chronic disease burden, I’m very bullish on the healthcare sector over the next decade.

I think this could arguably make it one of the best areas of the market to make buy and hold investments.

Here are three healthcare shares which I would consider buying for the long-term today:

Although the CSL Limited (ASX: CSL) share price has rallied a massive 42% so far this year, I still believe the biotherapeutics company could be a great long-term buy and hold investment. Thanks to its industry leading and highly profitable immunoglobulins business, I believe CSL is capable of delivering above-average profit growth for the foreseeable future.

The Nanosonics Ltd. (ASX: NAN) share price has fallen around 15% year-to-date following last year’s meteoric rise. I believe this has left the shares of this infection control specialist trading at a great price for buy and hold investors. Demand for its trophon EPR ultrasound probe disinfection system has been growing strongly for the last few years. Thanks to changes to guidelines, I expect demand to continue to increase for a while to come.

The Ramsay Health Care Limited (ASX: RHC) share price is up around 3% this year. With demand for healthcare services expected to increase strongly over the next decade as populations around the world age, I think Ramsay and its hospitals are positioned perfectly to profit. Because of this I feel Ramsay is one of the best buy and hold investment options on the Australian share market.

As well as CSL, Nanosonics, and Ramsay, I think these three shares could also be great buy and hold investments as well.

Each has been growing earnings at a strong rate and I expect more of the same in FY 2018.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

HOT OFF THE PRESSES: My #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.